RET and thyroid gland undifferentiated (anaplastic) carcinoma: Recurring non-canonical activating mutations included RET E511K (n = 3) which was identified in patients with anaplastic thyroid cancer, endometrial adenocarcinoma, and Merkel cell carcinoma.